Celator Pharmaceuticals Inc·4

Feb 27, 5:14 PM ET

Celator Pharmaceuticals Inc 4

4 · Celator Pharmaceuticals Inc · Filed Feb 27, 2015

Insider Transaction Report

Form 4
Period: 2015-02-25
Mayer Lawrence David
President and Head of Research
Transactions
  • Award

    Common Stock

    2015-02-25+7,63918,100 total
  • Award

    Stock Option, Right to Buy

    2015-02-25+80,00080,000 total
    Exercise: $2.79Exp: 2025-02-25Common Stock (80,000 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    7,468
  • Common Stock

    (indirect: By Trust)
    3,631
Footnotes (1)
  • [F1]The options vest as follows: (i) 20,000 options vest on February 25, 2016; and (ii) 12 consecutive quarterly installments of 5,000 options vest on the 25th day of each May, August, November and February, beginning May 125, 2016 and continuing through February 25, 2019.

Documents

1 file
  • 4
    v403091_4.xmlPrimary

    OWNERSHIP DOCUMENT